Myria Biosciences
PrivateLast Round
Pre Seed
Jun 20, 2024
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Myria Biosciences operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Pre Seed round in June 2024.
Myria Biosciences is a biotechnology company that develops therapeutic molecules using its synthetic intelligence platform to transform drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Myria Biosciences Comparables
Compare Myria Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomia | 87% | |
| Generare | 84% | |
| Protuoso Biosciences | 82% |
For institutional investors. Book with your work email.
Myria Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Myria Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Capital Blue Partners | Pre Seed |
| Rockmount Seed Investments | Pre Seed |
| The Creator Fund | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 67% MoM.
- Jan 5, 2026
Monthly visitors increased 46% MoM.
For institutional investors. Book with your work email.
Myria Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Myria Biosciences's valuation, stock price, and market status.
Is Myria Biosciences a public or private company?
Myria Biosciences is a private company.
What is the current stock price of Myria Biosciences?
Myria Biosciences is a private company, so its shares have no public market price. Caplight tracks Myria Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Myria Biosciences worth (valuation)?
Valuation information for Myria Biosciences is not publicly available.
Can I buy Myria Biosciences stock?
Myria Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Myria Biosciences's last funding round?
Myria Biosciences's most recent funding round was Pre Seed on June 20, 2024.
Who are the main investors in Myria Biosciences?
Key investors in Myria Biosciences include The Creator Fund.
Will Myria Biosciences IPO soon?
No public IPO plans have been announced for Myria Biosciences.
How can I track Myria Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Myria Biosciences's shares on secondary markets.